Background: The fecal occult blood test (FOBT) is widely accepted as the most
In the present study, we examined gas components in bowel movements from patients with CRC using a novel method and evaluated the diagnostic value of this method for CRC.
| ME TH ODS

| Patients
This was a prospective observational study at Yokohama City University Hospital and Yokohama City University Medical Center.
Inclusion criteria were age 20 years or older, histologically proven adenocarcinoma, any clinical stage, and elective operation for CRC.
Exclusion criteria were concurrent malignancy in another organ, inflammatory bowel disease, infectious enteritis, bowel obstruction or the inability to tolerate surgery under general anesthesia. A total of 30 patients with CRC who were scheduled for surgery were enrolled in this study from July 2014 to April 2015. Gas samples were collected from the patients before starting preoperative bowel preparation. Twenty-six healthy adult volunteers were enrolled as a control group. This study was approved by the Yokohama City University Ethics Committee and was conducted in accordance with the Ethical Guidelines for Medical and Health Research Involving Human Subjects (IRB number B140703028), and all patients provided informed consent before any study procedure was carried out. This study is registered on the University Hospital Medical Information Network (UMIN) Center (UMIN000028256).
| Gas analysis
| Apparatus for gas sampling
As shown in Figure 1 , a gas sampling apparatus was placed in a toilet in the hospital ward. Defecation gas samples from patients were collected from the toilet into a 25-L sampling bag (500 mm 9 700 mm). The sampling bag was made of fluorinated vinyl resin (Tedlar bag, DuPont, Wilmington, WA, USA), and a Teflon flexible pipe was connected to a fan and the Tedlar bag. A commercial gas sensor (semiconductor gas sensor, TGS2600; FIGARO Engineering, Osaka, Japan) was arranged at the rear of the fan, and a stopper was used at the junction between the Tedlar bag and Teflon flexible pipe.
F I G U R E 1 Gas sampling system 2.2.2 | Collecting gas components during defecation Gas components were collected during defecation as follows: (i) Air in the toilet was aspirated with a fan (50 L/min) and passed through a commercial gas sensor. (ii) The stopper automatically opened immediately after the gas sensor detected gas components. (iii) The stopper closed after 30 seconds. (iv) The Tedlar bag was sealed with a large clip. To measure background gas, air in the toilet was aspirated when the toilet was not in use.
| Measurement of methyl mercaptan and hydrogen sulfide concentrations
In the defecation gas samples, we measured the content of sulfur-containing compounds methyl mercaptan (MM) and hydrogen sulfide (H 2 S). Volatile sulfur-containing compounds were analyzed by gas chromatography using a Sulfur Chemiluminescence Detector (GC/SCD) (Agilent Technologies, Santa Clara, CA, USA.). Briefly, gases collected in the Tedlar bag were aspirated into a cold-trapping tube, injected into the gas chromatography system by an Entech 7100A Preconcentrator (Entech Instruments Inc., Simi Valley, CA, USA) and then analyzed.
| Measurement of hydrogen, carbon dioxide, and methane concentrations
Hydrogen (H 2 ), methane (CH 4 ) and carbon dioxide (CO 2 ) were analyzed by gas chromatography using a thermal conductivity detector (GC/TCD) (Agilent 490 Micro GC; Agilent Technologies). Then, gases collected in the Tedlar bag were injected into the gas chromatography system and analyzed.
| Calculation of gas amounts during defecation
Concentrations of background gases were ignored because the concentration of background gas (except for CO 2 ) was sufficiently lower than the concentration of gas during defecation. The amount of gas during defecation was calculated by multiplying the gas concentration and the aspirated gas volume.
| Statistical analysis
When samples were recorded more than once, mean and standard deviation (SD) were calculated and used for subsequent analyses.
Patient characteristics are expressed as numbers and percentages or means AE SD as appropriate. A t test was used to evaluate the significance of the differences in continuous variables. Using a multivariate logistic regression model, we developed a formula to discriminate between CRC patients and healthy volunteers by using gas data from study participants. A formula was calculated by discriminant analysis using factors that had a significant difference by multivariate analysis. All analyses were carried out using IBM SPSS, version 21 (SPSS Inc., Chicago, IL, USA) and SAS version 9.3 (SAS Institute Inc., Cary, NC, USA).
| RESULTS
| Patient characteristics
Characteristics of the CRC group are shown in Table 1 , and 17 males and 13 females were included, with the average age being 68 years.
Twenty-two patients had colon cancer, and eight patients had rectal cancer. Although the most common tumor site was the rectum (n = 8), other primary tumors were located in the sigmoid colon (n = 7), cecum (n = 6), rectosigmoid colon (n = 5), transverse colon (n = 2), ascending colon (n = 1), and descending colon (n = 1). Mean tumor size was 3.8 cm. There were nine cases of stage I disease, 12 stage II disease, six stage III disease, and three stage IV disease. The control group included 22 males and four females, and the mean age was 37 years.
3.2 | Gas compound measurements obtained from the sampling apparatus The control group was younger than the CRC group. To consider the effect of age, we compared the findings from the younger and older healthy controls and found that there were no significant differences in the amount of any gas compound between the two groups (data not shown).
| Correlations between gas compound amounts and clinicopathological status of CRC patients
Correlations between gas compound amounts and clinicopathological status of CRC patients are shown in Table 2 . The amount of H 2 was significantly lower in patients with T3/4 tumors and advanced-stage disease than that in other CRC patients. For the other gas compounds, no significant correlations were observed with the clinicopathological status of CRC patients.
| Logistic regression analysis and discriminant analysis
Multivariate logistic regression analysis was carried out to identify CRC patients (Table 3) , and a total of 56 data sets (30 CRC patients and 26 controls) were used. When there were two or more samples, an average value was used for logistic regression analysis. The receiver operating characteristic (ROC) curve of the discriminant formula is shown in Figure 3 . Sensitivity, specificity, negative predictive value (NPV), PPV, and accuracy of the discriminant formula were 90%, 57.7%, 83.3%, 75%, and 75%, respectively.
F I G U R E 2
Comparison between gas compounds in the CRC and control groups (box plot). CH 4 , methane; CO 2 , carbon dioxide; CRC, colorectal cancer; H 2 , hydrogen; H 2 S, hydrogen sulfide; MM, methyl mercaptan
| DISCUSSION
To our knowledge, our study is the first to analyze fecal gas compounds from CRC patients using an extremely non-invasive technique. Our data show that the amount of gas compounds obtained during defecation was significantly different between CRC patients and controls.
The first analysis of VOC was reported in 1971 by Pauling et al, 13 who identified several hundred VOC in human breath and urine by using gas chromatography-mass spectrometry. Moreover, several authors have shown the usefulness of VOC for detecting CRC in different substances. These studies showed fair reliability, with sensitivities ranging from 30% to 94% and specificities ranging from 60% to 94%. In our study, the sensitivity was 90%, the The first limitation of the present study was its small sample size and, as this was a cross-sectional study of a CRC group and a control group, the second limitation was that the predictive value of the gas compound for screening an unselected population is not yet known. Moreover, we could not compare data from the gas compound analysis and FOBT because we did not have data from FOBT of patients and healthy volunteers. The third limitation was that the reason for the differences in gas compounds between CRC patients and healthy controls was unclear. Gas composition is probably affected by meals and, unfortunately, information regarding the food of CRC patients and controls was not accessible. Thus, further study of the association between consumed food, colonic flora and gas compound production is warranted. Furthermore, a large-scale trial comparing our method with the FOBT, which is a standard screening method, is necessary to confirm the usefulness of our method for CRC screening.
In conclusion, our study showed that analyzing gas compounds from defecation might provide a complete and non-invasive metabolomics biomarker profile that could be used as a diagnostic tool. 
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